What changed in this filing

/stocks — the workspaceLOADING

Item 2. Unregistered Sales of Equity Securities

2021-06-11 compared with 2020-11-16 · 6 added, 56 removed, 3 unchanged (95% of the section changed)

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

May 16, 2019, our Sponsor purchased an aggregate of 8,625,000 Founder Shares for $25,000, or approximately $0.003 per share.

Founder Shares will automatically convert into shares of our Class A common stock at the time of our initial business combination.

On July 25, 2019, our Sponsor transferred an aggregate of 80,000 Founder Shares to two of our independent directors at their original

purchase price.

In September 2019, our Sponsor forfeited an aggregate of 772,059 Founder Shares.

On July 31, 2020, our Sponsor

transferred an aggregate of 40,000 Founder Shares to our third independent director at their original purchase price.

Shares were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2)

of the Securities Act.

Simultaneously

with the consummation of our Public Offering, our Sponsor purchased from the Company an aggregate of 5,333,333 Private Placement

Warrants at a price of $1.50 per Private Placement Warrant (for a purchase price of approximately $8.0 million).

simultaneously with the closing of the sale of the Over-allotment Units, we consummated the sale of an additional 188,235 Private

Placement Warrants in a private placement to our Sponsor, generating gross proceeds of approximately $282,000.

Each Private Placement

Warrant entitles the holder thereof to purchase one share of our Class A common stock at an exercise price of $11.50 per share.

The sales of the Private Placement Warrants were made pursuant to the exemption from registration contained in Section 4(a)(2)

of the Securities Act.

July 30, 2019, we consummated the Public Offering of 30,000,000 Units.

The Units were sold at a price of $10.00 per Unit, generating

gross proceeds of $300.0 million.

Certain of our officers and directors purchased 200,000 of the 30,000,000 Units sold in the

Public Offering for an aggregate purchase price of $2.0 million.

The underwriters were granted a 45-day option from the date of

the final prospectus relating to the Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if

any, at $10.00 per Unit, less underwriting discounts and commissions.

On September 4, 2019, the underwriters partially exercised

the over-allotment option and, on September 6, 2019, the underwriters purchased 1,411,763 of the Over-allotment Units, generating

gross proceeds of approximately $14.1 million.

The remaining over-allotment option subsequently expired.

July 30, 2019, simultaneously with the closing of the Public Offering, we completed the private sale of 5,333,333 Private Placement

Warrants at a purchase price of $1.50 per Private Placement Warrant to our Sponsor, generating gross proceeds of approximately

$8.0 million.

Simultaneously with the closing of the sale of the Over-allotment Units, we completed the private sale of an additional

188,235 Private Placement Warrants at a purchase price of $1.50 per Private Placement Warrant to our Sponsor, generating gross

proceeds of approximately $282,000.

LLC, Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, RBC Capital Markets, LLC and Tudor, Pickering,

Securities, Inc.

served as underwriters for the Public Offering.

The securities sold in the Public Offering were

registered under the Securities Act on a registration statement on Form S-1 (File No.

333-232501) (the “Registration Statement”).

The SEC declared the Registration Statement effective on July 25, 2019.

May 10, 2019 (inception) through December 31, 2019, we incurred approximately $17.7 million for costs and expenses related to

the Public Offering, including an up-front fee of approximately $6.24 million in underwriting discounts and commissions and approximately

$10.92 million in deferred underwriting discounts and commissions, which amount will be payable upon consummation of our initial

business combination.

Prior to the closing of the Public Offering, our Sponsor loaned us approximately $251,000 under a promissory

note (the “Note”).

We repaid this Note to our Sponsor on August 12, 2019.

There has been no material change in the

planned use of proceeds from the Public Offering as described in our final prospectus filed with the SEC on July 29, 2019.

deducting the underwriting discounts and commissions (excluding the deferred portion of approximately $10.92 million, which amount

will be payable upon consummation of our initial business combination) and offering expenses, the total net proceeds from the

Public Offering and the sale of the Private Placement Warrants were approximately $315.1 million, of which approximately $314.1

million (or $10.00 per share sold in the Public Offering) was placed in the Trust Account.

Recent Sales of Unregistered Securities

The information required by this Item 2 is contained in our Current Report on Form 8-K, as originally

filed with the SEC on March 1, 2021 and as subsequently amended on April 1, 2021.

Issuer Purchases of Equity Securities

DEFAULTS UPON SENIOR SECURITIES

Not applicable.

MINE SAFETY DISCLOSURES

Not applicable.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Unregistered Sales of Equity Securities